IG Living Magazine Announces First Annual Essay Contest

TEMECULA, CA--(Marketwire - Apr 11, 2011) - IG Living! magazine has just launched its first annual Essay Contest, offering the publication's readers, Facebook fans and others within the IG community the opportunity to have their winning essay published in an upcoming issue.

"Our readers find it empowering to share their stories and help others who are dealing with the challenges of chronic illness," says Ronale Tucker-Rhodes, editor-in-chief, IG Living magazine. "The contest is open to patients who depend on intravenous immune globulin (IVIG), and their caregivers, and will provide a platform for budding writers with aspirations to be published in a national magazine."

IG Living announced the rules of the contest in a post on its blog last Friday. Entrants will be asked to begin their essay with the following lead sentence: "If I knew then what I know now, I would have..." The first place winner will receive a Kindle eReader and have their essay published in an upcoming issue of the magazine. Second and third place entries will each receive a $50 gift card and be published in the blog. For complete details, rules and guidelines, visit www.igliving.com/BlogEngine.

IG Living reaches nearly 30,000 readers bimonthly, including more than 19,000 physicians, nurses, case managers and other healthcare professionals involved in treating patients with IG products. For more information or to subscribe, visit www.IGLiving.com.

About IG Living

IG Living is the only magazine dedicated to patients who use immune globulin products and to their care providers. IG Living launched its first bimonthly issue in February-March 2006, with an initial distribution of 25,000 -- direct to patients and their physicians' offices. Regular features include such topics as product and manufacturer news, resources for healthy living, immune globulin treatment options, reimbursement and clinical trials. IG Living is published by FFF Enterprises, Inc.

About FFF Enterprises, Inc.

FFF Enterprises is the largest and most trusted distributor of plasma products, vaccines and other biopharmaceuticals in the U.S. Founded in 1988, FFF is now in its 23^rd year with more than a billion dollars in annual sales and a flawless safety track record. FFF has taken a leadership position in regards to supply chain safety and innovation, setting new standards and pioneering industry firsts. FFF's commitment to Guaranteed Channel Integrity™ ensures that products are purchased only from the manufacturer and shipped only to healthcare providers, with additional steps taken to safely store, handle and ship products to ensure patient safety is never compromised. FFF's proprietary systems, Verified Electronic Pedigree™ and Lot-Track™, provide verification of this secure channel, and FFF's MyFluVaccine (www.MyFluVaccine.com) and VaxAmerica (www.VaxAmerica.com) are revolutionary vaccination programs that have added a new level of safety, convenience and reliability to both healthcare providers and consumers.